A randomized trial of high- versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infection

Journal of Infectious Diseases

Volumn 179, Issue 4, 1999, Pages 849-858

  Davey Jr , Richard T ^b   Chaitt, Doreen G ^c   Albert, Jeffrey M ^c   Piscitelli, Stephen C ^c   Kovacs, Joseph A ^c   Walker, Robert E ^c   Falloon, Judith ^c   Polis, Michael A ^c   Metcalf, Julia A ^c   Masur, Henry ^c   Dewar, Robin ^c   Baseler, Michael ^c   Fyfe, Gwendolyn ^a   Giedlin, Martin A ^c   Clifford Lane, H ^c  

^a GENENTECH INC   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2;

ADULT; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; FATIGUE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSOMNIA; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMATITIS; SUBCUTANEOUS DRUG ADMINISTRATION; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; CD4 LYMPHOCYTE COUNT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HIV-1; HUMANS; INJECTIONS, SUBCUTANEOUS; INTERLEUKIN-2; MALE; MIDDLE AGED;

EID: 0001027244     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314678     Document Type: Article

References (17)

1. Kovacs JA, Baseler M, Dewar RJ, et al. Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study. N Engl J Med 1995; 332:567-75.
2. 1: results of a randomized, controlled trial. N Engl J Med 1996; 335:1350-6.
3. Schwartz DH, Skowron G, Merigan TC. Safety and effects of interleukin-2 plus zidovudine in asymptomatic individuals infected with human immunodeficiency virus. J Acquir Immune Defic Syndr 1991; 4:11-23.
4. 1 [abstract We.B.292]. In Program and abstracts: XI International Conference on AIDS/International Conference on STD (Vancouver), 1996.
5. Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med 1997; 337:725-33.
6. Gulick RM, Mellors JW, Havlir D, et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 1997; 337:734-9.
7. Clark AG, Holodmiy M. Schwartz DH. Katzenstein DA, Merigan TC. Decrease in HIV provirus in peripheral blood mononuclear cells during zidovudine and human rIL-2 administration. J Acquir Immune Defic Syndr 1992; 5:52-9.
8. Finzi D, Hermankova M, Pierson T, et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997; 278:1295-300.
9. McMahon DK, Armstrong JA, Huang XL, et al. A phase I study of subcutaneous recombinant interleukin-2 in patients with advanced HIV disease while on zidovudine. AIDS 1994; 8:59-66.
10. Davey RT Jr, Chaitt DG, Piscitelli SC, et al. Subcutaneous administration of interleukin-2 in HIV-1 infected persons. J Infect Dis 1997; 175:781-9.
11. De Paoli P, Zanussi S, Simonelli C, et al. Effects of subcutaneous interleukin-2 therapy on CD4 subsets and in vitro cytokine production in HIV-positive subjects. J Clin Invest 1997; 100:2737-43.
12. + T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat Med 1997; 3:533-40.
13. Piscitelli SC, Wells M, Metcalf JA, Baseler M, Stevens R, Davey RT Jr. Pharmacokinetics and pharmacodynamics of subcutaneously administered interleukin-2 in HIV-infected patients. Pharmacotherapy 1996; 16:754-9.
14. - T-cell determinations in persons with human immunodeficiency virus (HIV) infections. MMWR Morb Mortal Wkly Rep 1994; 43(RR-3):1-21.
15. Urdea MS, Wilber JC, Yeghiazarian T, et al. Direct and quantitative detection of HIV-1 RNA in human plasma with a branched DNA signal amplification assay. AIDS 1993; 7(suppl 2):S11-4.
16. Dewar R, Highbarger HC, Sarmiento MD, et al. Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. J Infect Dis 1994; 170:1172-9.
17. Akritas MG, Arnold SF, Brunner E. Nonparametric hypothesis and rank statistics for unbalanced factorial designs. J Am Stat Assoc 1997; 92:258-65.